A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection

Clin Immunol. 2020 Jul:216:108442. doi: 10.1016/j.clim.2020.108442. Epub 2020 Apr 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19*
  • Humans
  • Macrophages
  • Monocytes
  • SARS-CoV-2

Substances

  • Antiviral Agents